Viewing Study NCT06496841



Ignite Creation Date: 2024-07-17 @ 10:53 AM
Last Modification Date: 2024-10-26 @ 3:34 PM
Study NCT ID: NCT06496841
Status: COMPLETED
Last Update Posted: 2024-07-11
First Post: 2024-07-04

Brief Title: Transnasal Versus Suprazygomatic SPG Block in Persistant Idiopathic Facial Pain
Sponsor: Diskapi Teaching and Research Hospital
Organization: Diskapi Teaching and Research Hospital

Study Overview

Official Title: A Comparison of Transnasal Versus Ultrasound-guided Suprazygomatic Approaches for Sphenopalatine Ganglion Blocks in Persistent Idiopathic Facial Pain
Status: COMPLETED
Status Verified Date: 2024-08
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The International Headache Society defines persistent idiopathic facial pain PIFP as persistent facial pain that does not have the characteristics of cranial neuralgia is blunt persistent persistent bothersome and not attributable to another disorder The management of persistent idiopathic facial pain PIFP is complex The sphenopalatine ganglion SPG has been the target of interventional treatment of many facial pain syndromes The sphenopalatine ganglion can be accessed by transnasal access and ultrasound or scopy guidance In this study datas compared the efficacy of transnasal approach and ultrasound-guided suprazigomatic approach in sphenopalatine ganglion block in patients with persistent idiopathic facial pain
Detailed Description: Patients with chronic head and facial pain are frequently referred to us and some of these patients are persistent idiopathic facial pain patients who do not respond to conservative treatment Various interventional treatment modalities can be applied to these patients One of the treatments we frequently apply is sphenopalatine ganglion SPG blockage which has an important place in the pathogenesis of chronic headache The SPG is the target area for the treatment of cluster headache migraine postherpetic neuralgia trigeminal neuralgia and other atypical facial pain syndromes due to its anatomical localisation and its role in the trigemino-cervical reflex Although there are various techniques for SPG block the simplest and most easily applicable is the transnasal approach and the traditional method is to apply a block with a cotton-tipped swab Various local anaesthetics can be used the most commonly used local anaesthetic is 2-3 ml of 2 or 10 lidocaine usually administered through one nostril for 30 minutes It is also possible to access SPG via the suprazygomatic route and studies have shown that SPG block applied via the suprazygomatic route provides effective treatment of chronic headaches In ultrasound-guided SPG block after visualising the pterygopalatine fossa with USG 3-4 mL of 2 lidocaine is administered to the area and blockage is achieved

Our study was designed retrospectively The primary aim of the study was to compare the efficacy of transnasal and suprazigomatic routes based on Numerical Rating Scale NRS pain scores by reviewing the files of patients who underwent sphenopalatine ganglion block for persistent idiopathic facial pain The pain scores recorded before the procedure and one and four weeks after the procedure will be compared

In this study primary aim is to evaluate the efficacy of these two treatment modalities with retrospectively evaluate the Visual Analogue Scale VAS score HIT-6 Headache Impact Test-6 score and headache diary data of the patients who have previously undergone these treatments in the pain clinic

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None